Therapeutic roles of carbon monoxide in intestinal ischemia-reperfusion injury

Journal of Gastroenterology and Hepatology (Australia)

Volumn 30, Issue S1, 2015, Pages 46-52

  Katada, Kazuhiro ^a   Takagi, Tomohisa ^a   Uchiyama, Kazuhiko ^a   Naito, Yuji ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Carbon monoxide; Cytoprotection; Heme oxygenase; Ischemia reperfusion injury; Oxidative stress

Indexed keywords

CARBON MONOXIDE; HEME OXYGENASE; ANTIINFLAMMATORY AGENT; HEME; HEME OXYGENASE 1;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; DRUG DELIVERY SYSTEM; HUMAN; INTESTINE ISCHEMIA; NONHUMAN; PRIORITY JOURNAL; THERAPY EFFECT; ANIMAL; INTESTINAL DISEASES; METABOLISM; PHYSIOLOGY; REPERFUSION INJURY;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CARBON MONOXIDE; HEME; HEME OXYGENASE-1; HUMANS; INTESTINAL DISEASES; REPERFUSION INJURY;

EID: 84925945692     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/jgh.12742     Document Type: Article

References (74)

1. Acosta S. Epidemiology of mesenteric vascular disease: clinical implications. Semin. Vasc. Surg. 2010; 23: 4-8.
2. Yasuhara H. Acute mesenteric ischemia: the challenge of gastroenterology. Surg. Today 2005; 35: 185-195.
3. Maines MD. The heme oxygenase system: a regulator of second messenger gases. Annu. Rev. Pharmacol. Toxicol. 1997; 37: 517-554.
4. McCoubrey WK Jr, Huang TJ, Maines MD. Isolation and characterization of a cDNA from the rat brain that encodes hemoprotein heme oxygenase-3. Eur. J. Biochem. 1997; 247: 725-732.
5. Brouard S, Otterbein LE, Anrather J etal. Carbon monoxide generated by heme oxygenase 1 suppresses endothelial cell apoptosis. J. Exp. Med. 2000; 192: 1015-1026.
6. Morse D, Sethi J. Carbon monoxide and human disease. Antioxid. Redox Signal. 2002; 4: 331-338.
7. Otterbein LE, Bach FH, Alam J etal. Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nat. Med. 2000; 6: 422-428.
8. Sarady JK, Otterbein SL, Liu F, Otterbein LE, Choi AM. Carbon monoxide modulates endotoxin-induced production of granulocyte macrophage colony-stimulating factor in macrophages. Am. J. Respir. Cell Mol. Biol. 2002; 27: 739-745.
9. Amersi F, Shen XD, Anselmo D etal. Ex vivo exposure to carbon monoxide prevents hepatic ischemia/reperfusion injury through p38 MAP kinase pathway. Hepatology 2002; 35: 815-823.
10. Kaizu T, Ikeda A, Nakao A etal. Protection of transplant-induced hepatic ischemia/reperfusion injury with carbon monoxide via MEK/ERK1/2 pathway downregulation. Am. J. Physiol. Gastrointest. Liver Physiol. 2008; 294: G236-244.
11. Nakahira K, Kim HP, Geng XH etal. Carbon monoxide differentially inhibits TLR signaling pathways by regulating ROS-induced trafficking of TLRs to lipid rafts. J. Exp. Med. 2006; 203: 2377-2389.
12. Hervera A, Leánez S, Negrete R, Motterlini R, Pol O. Carbon monoxide reduces neuropathic pain and spinal microglial activation by inhibiting nitric oxide synthesis in mice. PLoS ONE 2012; 7: e43693.
13. Horváth B, Hortobágyi L, Lenzsér G etal. Carbon monoxide-prostaglandin E2 interaction in the hypothalamic circulation. Neuroreport 2008; 19: 1601-1604.
14. Lee LY, Kaizu T, Toyokawa H etal. Carbon monoxide induces hypothermia tolerance in Kupffer cells and attenuates liver ischemia/reperfusion injury in rats. Liver Transpl. 2011; 17: 1457-1466.
15. Kim HP, Wang X, Zhang J etal. Heat shock protein-70 mediates the cytoprotective effect of carbon monoxide: involvement of p38 beta MAPK and heat shock factor-1. J. Immunol. 2005; 175: 2622-2629.
16. Nakao A, Kimizuka K, Stolz DB etal. Carbon monoxide inhalation protects rat intestinal grafts from ischemia/reperfusion injury. Am. J. Pathol. 2003; 163: 1587-1598.
17. Otterbein LE, Mantell LL, Choi AM. Carbon monoxide provides protection against hyperoxic lung injury. Am. J. Physiol. 1999; 276: L688-694.
18. Nakao A, Moore BA, Murase N etal. Immunomodulatory effects of inhaled carbon monoxide on rat syngeneic small bowel graft motility. Gut 2003; 52: 1278-1285.
19. Pfeiffer H, Rojas A, Niesel J, Schatzschneider U. Sonogashira and "click" reactions for the N-terminal and side-chain functionalization of peptides with (Mn[CO]3[tpm])+-based CO releasing molecules (tpm=tris(pyrazolyl)methane). Dalton Trans. 2009; 14: 4292-4298.
20. Govender P, Pai S, Schatzschneider U, Smith GS. Next generation PhotoCORMs: polynuclear tricarbonylmanganese(I)-functionalized polypyridyl metallodendrimers. Inorg. Chem. 2013; 52: 5470-5478.
21. Takagi T, Naito Y, Mizushima K etal. Inhalation of carbon monoxide ameliorates TNBS-induced colitis in mice through the inhibition of TNF-alpha expression. Dig. Dis. Sci. 2010; 55: 2797-2804.
22. Moore BA, Overhaus M, Whitcomb J etal. Brief inhalation of low-dose carbon monoxide protects rodents and swine from postoperative ileus. Crit. Care Med. 2005; 33: 1317-1326.
23. Hegazi RA, Rao KN, Mayle A, Sepulveda AR, Otterbein LE, Plevy SE. Carbon monoxide ameliorates chronic murine colitis through a heme oxygenase 1-dependent pathway. J. Exp. Med. 2005; 202: 1703-1713.
24. Mayr FB, Spiel A, Leitner J etal. Effects of carbon monoxide inhalation during experimental endotoxemia in humans. Am. J. Respir. Crit. Care Med. 2005; 171: 354-360.
25. Motterlini R, Clark JE, Foresti R, Sarathchandra P, Mann BE, Green CJ. Carbon monoxide-releasing molecules: characterization of biochemical and vascular activities. Circ. Res. 2002; 90: E17-24.
26. Motterlini R, Mann BE, Johnson TR, Clark JE, Foresti R, Green CJ. Bioactivity and pharmacological actions of carbon monoxide-releasing molecules. Curr. Pharm. Des. 2003; 9: 2525-2539.
27. Clark JE, Naughton P, Shurey S etal. Cardioprotective actions by a water-soluble carbon monoxide-releasing molecule. Circ. Res. 2003; 93: e2-8.
28. Cepinskas G, Katada K, Bihari A, Potter RF. Carbon monoxide liberated from carbon monoxide-releasing molecule CORM-2 attenuates inflammation in the liver of septic mice. Am. J. Physiol. Gastrointest. Liver Physiol. 2008; 294: G184-191.
29. Sawle P, Foresti R, Mann BE, Johnson TR, Green CJ, Motterlini R. Carbon monoxide-releasing molecules (CO-RMs) attenuate the inflammatory response elicited by lipopolysaccharide in RAW264.7 murine macrophages. Br. J. Pharmacol. 2005; 145: 800-810.
30. Urquhart P, Rosignoli G, Cooper D, Motterlini R, Perretti M. Carbon monoxide-releasing molecules modulate leukocyte-endothelial interactions under flow. J. Pharmacol. Exp. Ther. 2007; 321: 656-662.
31. Nakao A, Toyokawa H, Tsung A etal. Ex vivo application of carbon monoxide in University of Wisconsin solution to prevent intestinal cold ischemia/reperfusion injury. Am. J. Transplant. 2006; 6: 2243-2255.
32. Nakao A, Huang CS, Stolz DB etal. Ex vivo carbon monoxide delivery inhibits intimal hyperplasia in arterialized vein grafts. Cardiovasc. Res. 2011; 89: 457-463.
33. Coeffier M, Le Pessot F, Leplingard A etal. Acute enteral glutamine infusion enhances heme oxygenase-1 expression in human duodenal mucosa. J. Nutr. 2002; 132: 2570-2573.
34. Takagi T, Naito Y, Okada H etal. Lansoprazole, a proton pump inhibitor, mediates anti-inflammatory effect in gastric mucosal cells through the induction of heme oxygenase-1 via activation of NF-E2-related factor 2 and oxidation of kelch-like ECH-associating protein 1. J. Pharmacol. Exp. Ther. 2009; 331: 255-264.
35. Alam J, Cook JL. How many transcription factors does it take to turn on the heme oxygenase-1 gene? Am. J. Respir. Cell Mol. Biol. 2007; 36: 166-174.
36. Sun J, Hoshino H, Takaku K etal. Hemoprotein Bach1 regulates enhancer availability of heme oxygenase-1 gene. EMBO J. 2002; 21: 5216-5224.
37. Zhao HD, Zhang F, Shen G etal. Sulforaphane protects liver injury induced by intestinal ischemia reperfusion through Nrf2-ARE pathway. World J. Gastroenterol. 2010; 16: 3002-3010.
38. Mito S, Ozono R, Oshima T etal. Myocardial protection against pressure overload in mice lacking Bach1, a transcriptional repressor of heme oxygenase-1. Hypertension 2008; 51: 1570-1577.
39. Harusato A, Naito Y, Takagi Y etal. Inhibition of Bach1 ameliorates indomethacin-induced intestinal injury in mice. J. Physiol. Pharmacol. 2009; 60: 149-154.
40. Granger DN, Richardson PD, Kvietys PR, Mortillaro NA. Intestinal blood flow. Gastroenterology 1980; 78: 837-863.
41. Vollma B, Menger MD. Intestinal ischemia/reperfusion: microcirculatory pathology and functional consequences. Langenbecks Arch. Surg. 2011; 396: 13-29.
42. Haglund U. Gut ischaemia. Gut 1994; 35: S73-76.
43. Hernandez LA, Grisham MB, Twohig B, Arfors KE, Harlan JM, Gramger DN. Role of neutrophils in ischemia-reperfusion-induced microvascular injury. Am. J. Physiol. 1987; 253: H699-703.
44. Kubes P, Hunter J, Granger DN. Ischemia/reperfusion-induced feline intestinal dysfunction: importance of granulocyte recruitment. Gastroenterology 1992; 103: 807-812.
45. Blackwell TS, Yull FE, Chen CL etal. Multiorgan nuclear factor kappa B activation in a transgenic mouse model of systemic inflammation. Am. J. Respir. Crit. Care Med. 2000; 162: 1095-1101.
46. Kojima M, Tanabe M, Shinoda M etal. Role of high mobility group box chromosomal protein 1 in ischemia-reperfusion injury in the rat small intestine. J. Surg. Res. 2012; 178: 466-471.
47. Panes J, Perry M, Granger DN. Leukocyte-endothelial cell adhesion: avenues for therapeutic intervention. Br. J. Pharmacol. 1999; 126: 537-550.
48. Chen Y, Lui VC, Rooijen NV, Tam PK. Depletion of intestinal resident macrophages prevents ischaemia reperfusion injury in gut. Gut 2004; 53: 1772-1780.
49. Zhang X, Mosser DM. Macrophage activation by endogenous danger signals. J. Pathol. 2008; 214: 161-178.
50. Camhi SL, Alam J, Otterbein L, Sylvester SL, Choi AM. Induction of heme oxygenase-1 gene expression by lipopolysaccharide is mediated by AP-1 activation. Am. J. Respir. Cell Mol. Biol. 1995; 13: 387-398.
51. Shokawa T, Yoshizumi M, Yamamoto H etal. Induction of heme oxygenase-1 inhibits monocyte chemoattractant protein-1 mRNA expression in U937 cells. J. Pharmacol. Sci. 2006; 100: 162-166.
52. Tsoyi K, Nizamutdinova IT, Janq HJ etal. Carbon monoxide from CORM-2 reduces HMGB1 release through regulation of IFN-beta/JAK2/STAT-1/INOS/NO signaling but not COX-2 in TLR-activated macrophages. Shock 2010; 34: 608-614.
53. Srisook K, Han SS, Choi HS etal. CO from enhanced HO activity or from CORM-2 inhibits both O2- and NO production and downregulates HO-1 expression in LPS-stimulated macrophages. Biochem. Pharmacol. 2006; 71: 307-318.
54. Chung SW, Liu X, Macias AA, Baron RM, Perrella MA. Heme oxygenase-1-derived carbon monoxide enhances the host defense response to microbial sepsis in mice. J. Clin. Invest. 2008; 118: 239-247.
55. Lee S, Lee SJ, Coronata AA etal. Carbon monoxide confers protection in sepsis by enhancing beclin 1-dependent autophagy and phagocytosis. Antioxid. Redox Signal. 2014; 20: 432-442.
56. Ley K, Laudanna C, Cybulsky MI, Nourshargh S. Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat. Rev. Immunol. 2007; 7: 678-689.
57. Hayashi S, Takamiya R, Yamaguchi T etal. Induction of heme oxygenase-1 suppresses venular leukocyte adhesion elicited by oxidative stress: role of bilirubin generated by the enzyme. Circ. Res. 1999; 85: 663-671.
58. Wunder C, Brock RW, McCarter SD etal. Inhibition of haem oxygenase activity increases leukocyte accumulation in the liver following limb ischaemia-reperfusion in mice. J. Physiol. 2002; 540: 1013-1021.
59. Masini E, Vannacci A, Mastroianni R etal. A carbon monoxide-releasing molecule (CORM-3. abrogates polymorphonuclear granulocyte-induced activation of endothelial cells and mast cells. FASEB J. 2008; 22: 3380-3388.
60. Taille C, El-Benna J, Motterlini R. Mitochondrial respiratory chain and NAD(P)H oxidase are targets for the antiproliferative effect of carbon monoxide in human airway smooth muscle. J. Biol. Chem. 2005; 280: 25350-25360.
61. Mizuguchi S, Stephen J, Bihari R etal. CORM-3-derived CO modulates polymorphonuclear leukocyte migration across the vascular endothelium by reducing levels of cell surface-bound elastase. Am. J. Physiol. Heart Circ. Physiol. 2009; 297: H920-929.
62. Sheikh SZ, Hegazi RA, Kobayashi T etal. An anti-inflammatory role for carbon monoxide and heme oxygenase-1 in chronic Th2-mediated murine colitis. J. Immunol. 2011; 186: 5506-5513.
63. Lee SS, Gao W, Mazzola S etal. Heme oxygenase-1, carbon monoxide, and bilirubin induce tolerance in recipients toward islet allografts by modulating T regulatory cells. FASEB J. 2007; 21: 3450-3457.
64. Soares MP, Seldon MP, Gregoire IP etal. Heme oxygenase-1 modulates the expression of adhesion molecules associated with endothelial cell activation. J. Immunol. 2004; 172: 3553-3563.
65. Mizuguchi S, Capretta A, Suehiro S etal. Carbon monoxide-releasing molecule CORM-3 suppresses vascular endothelial cell SOD-1/SOD-2 activity while up-regulating the cell surface levels of SOD-3 in a heparin-dependent manner. Free Radic. Biol. Med. 2010; 49: 1534-1541.
66. Zhang X, Shan P, Alam J, Fu XY, Lee PJ. Carbon monoxide differentially modulates STAT1 and STAT3 and inhibits apoptosis via a phosphatidylinositol 3-kinase/Akt and p38 kinase-dependent STAT3 pathway during anoxia-reoxygenation injury. J. Biol. Chem. 2005; 280: 8714-8721.
67. Song H, Bergstrasser C, Rafat N etal. The carbon monoxide releasing molecule (CORM-3. inhibits expression of vascular cell adhesion molecule-1 and E-selectin independently of haem oxygenase-1 expression. Br. J. Pharmacol. 2009; 157: 769-780.
68. Zabalgoitia M, Colston JT, Reddy SV etal. Carbon monoxide donors or heme oxygenase-1 (HO-1 overexpression blocks interleukin-18-mediated NF-kappaB-PTEN-dependent human cardiac endothelial cell death. Free Radic. Biol. Med. 2008; 44: 284-298.
69. Uchiyama K, Naito Y, Takagi T etal. Carbon monoxide enhance colonic epithelial restitution via FGF15 derived from colonic myofibroblasts. Biochem. Biophys. Res. Commun. 2010; 391: 1122-1126.
70. Ahanger AA, Prawez S, Kumar D etal. Wound healing activity of carbon monoxide liberated from CO-releasing molecule (CO-RM). Naunyn Schmiedebergs Arch. Pharmacol. 2011; 384: 93-102.
71. Takagi T, Naito Y, Uchiyama K etal. Carbon monoxide-releasing molecule exerts an anti-inflammatory effect on dextran sulfate sodium-induced colitis in mice. Dig. Dis. Sci. 2011; 56: 1663-1671.
72. Nakao A, Kaczorowski DJ, Sugimoto R etal. Application of heme oxygenase-1, carbon monoxide and biliverdin for the prevention of intestinal ischemia/reperfusion injury. J. Clin. Biochem. Nutr. 2008; 42: 78-88.
73. Naito Y, Uchiyama K, Takagi T etal. Therapeutic potential of carbon monoxide (CO) for intestinal inflammation. Curr. Med. Chem. 2012; 19: 70-76.
74. Katada K, Bihari A, Mizuguchi S etal. Carbon monoxide liberated from CO-releasing molecule (CORM-2) attenuates ischemia/reperfusion (I/R)-induced inflammation in the small intestine. Inflammation 2010; 33: 92-100.